|
|
||||||||
REVIEW
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
gehod{at}mail.nih.gov
Recent advances in understanding the complex biology of the microenvironment that underlies tumor invasion and migration have revealed novel and promising therapeutic targets. Pharmacological blockade of intra- and extracellular signaling events that regulate migration and survival of multiple cell types may disrupt the host-tumor conspiracy that allows escape from normal developmental regulation.
This article has been cited by other articles:
![]() |
H.-Y. Yoon, K. Miura, E. J. Cuthbert, K. K. Davis, B. Ahvazi, J. E. Casanova, and P. A. Randazzo ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP J. Cell Sci., November 15, 2006; 119(22): 4650 - 4666. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tzukerman, T. Rosenberg, I. Reiter, S. Ben-Eliezer, G. Denkberg, R. Coleman, Y. Reiter, and K. Skorecki The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res., April 1, 2006; 66(7): 3792 - 3801. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |